Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event :
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
  • Shine Speaker Bureau:
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
  • Shine Advisor:
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
  • Shine Event Service:
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
Conference Sponsor
2023 - 03 - 21
Shaperon是一家位于韩国首尔,处于临床阶段的生物技术公司。2022年在韩国成功进入科斯达克(KOSDAQ)市场。由 Shaperon 开发的小分子候选药物是GPCR19 激动剂,可调节NF-Kb 转录因子和P2X7R 离子通道活性,从而抑制广谱促炎细胞因子。Shaperon 的小分子药物主要用于治疗多类炎症适应症,包括特应性皮炎、新冠肺炎、特发性肺纤维化、阿尔茨海默病。非酒精性脂肪肝炎和肥胖症。其中,针对特应性皮炎的药物 NuGel和针对新冠肺炎的药物-NuSepin 均已完成临床2 期的测试。同时,Shaperon还具有开发纳米抗体的技术平台,目前拥有处于临床前测试阶段的双特异性纳米抗体CD47-PD-L1。
2023 - 03 - 21
EirGenix is a global contract development and manufacturing organization CDMO providing high quality and cost-effectiveness service in support of its clients in the development, analytical testing, and cGMP manufacturing of biopharmaceuticals from pre-clinical to commercial manufacturing. EirGenix quality system follows global quality guidelines and has passed US FDA, Japan PDMA and Taiwan local TFDA GMP inspection for commercial supplies. EirGenix is also a leader in the development of HER2 related biosimilars. EirGenix has formed a licensing agreement with Sandoz to ex-China globally market of its self-developed trastuzumab biosimilar product. EirGenix provides a one-stop shop solution to its clients in the development and manufacturing of biologics around the world.
2023 - 03 - 21
上海优理惠生医药有限公司秉持“优异的科学,理想的药物”理念,为患者提供一系列包括采用合成致死策略在内的精准治疗组合。目前在研管线7个管线,其中有3个项目处于IND enabling阶段,预计2023年Q1有一个项目进入临床I期研究阶段。